K&S secures a complete defense verdict on behalf of CG Oncology in a dispute with ANI Pharmaceuticals over future royalties on net sales of cretostimogene or, in the alternative, $2.3B in unjust enrichment damages

In the News

July 31, 2025

| Global Legal Chronicle and The AmLaw Litigation Daily

Featured Lawyers:

Joseph D Eng, Jr.

Partner

Mark Zambarda

Senior Associate

Amanda J. Klingler

Partner

Lisa Ann Horvath

Partner

Eric Valuyev

Associate

David J. Farber

Partner

Go to the Global Legal Chronicle article

Go to the Law360 Pulse article

Go to The AmLaw Litigation Daily article

Related Capabilities

Explore King & Spalding

Capabilities

Innovative Drug, Biologic & Device Development

Learn More

Capabilities

Life Sciences & Healthcare

Learn More